---
title: "Australia's CSL slips to 14-1/2-month low on first-half profit miss"
date: "2025-02-11 12:13:24"
summary: "** Shares of CSL fall as much as 5.5% to A$255.4, their lowest levels since November 21, 2023 ** The biopharmaceutical co has reported half-year net profit of $2.01 billion, lower than analysts' forecast of $2.09 billion** Co says earnings weighed down by falling immunisation rates in the U.S., its..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Shares of CSL fall as much as 5.5% to A$255.4, their lowest levels since November 21,Â 2023

\*\* The biopharmaceutical co has reported half-year net profit of $2.01 billion, lower than analysts' forecast of $2.09 billion

\*\* Co says earnings weighed down by falling immunisation rates in the U.S., its largest market

\*\* About 1.2 million shares change hands, vs the 30-day average of 558,040

\*\* Stock fell 1.8% in 2024

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P2098:0-australia-s-csl-slips-to-14-1-2-month-low-on-first-half-profit-miss/)
